Clotrimazole

CAS 23593-75-1 7 current records 6 historicalSmall Molecule

Who holds supplier records for Clotrimazole? 7 organisations hold a current record for Clotrimazole: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Italy (3) and Spain (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Clotrimazole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/clotrimazole

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Clotrimazole expires 26 May 2042. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Clotrimazole. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Clotrimazole sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Clotrimazole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
AMOLI ORGANICS PRIVATE LIMITED MumbaiIN
CEP 2000-009 - Rev 02
Clotrimazole
Jul 2026—
SNJ LABS PRIVATE LIMITED RajkotIN
CEP 2024-445 - Rev 00
Clotrimazole
Jul 2026—
BAYER HISPANIA, S.L. LangreoES
CEP 2003-187 - Rev 03
Clotrimazole
May 2026Inspected Apr 2025
Spain
OLON S.P.A. RodanoIT
CEP 2004-102 - Rev 06
Clotrimazole
Mar 2025Inspected Mar 2025
Italy
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
CEP 2008-326 - Rev 03
Clotrimazole, Standard and micronised grade
Jul 2024Inspected Apr 2026
Italy
ERREGIERRE S.P.A. San Paolo D'ArgonIT
CEP 2005-176 - Rev 03
Clotrimazole
Jan 2024Inspected Nov 2025
Italy

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Clotrimazole are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • JIANGSU YUNYANG GROUP PHARMACEUTICAL CO LTD
    Inactive DMF 20397 · filed Apr 2007
  • China · Inactive DMF 19716 · filed Aug 2006
  • Italy · Inactive DMF 10713 · filed Feb 1994
  • Germany · Inactive DMF 6771 · filed Jan 1987
  • CUTTER BIOLOGICAL DIV MILES LABORATORIES INC
    Inactive DMF 6729 · filed Dec 1986
  • SIFAVITOR SRL
    Inactive DMF 5489 · filed Jul 1984

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (15 listed products contain Clotrimazole). The latest listed patent expires 26 May 2042. The latest listed exclusivity runs to 26 Sept 2037. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Clotrimazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL104).

Chemical identity

IUPAC name
1-[(2-chlorophenyl)-diphenylmethyl]imidazole
Canonical SMILES
C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4
InChIKey
VNFPBHJOKIVQEB-UHFFFAOYSA-N
Synonyms
Abtrim, Actavall, BAY 5097, BAY-5097, Candiden, Canesten, Canesten af, Canesten crm combi, Canesten internal, Canesten vc, Clotrimazol, Clotrimazole

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Azole Antifungal
Chemical structure
Azoles

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Clotrimazole?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Clotrimazole: AMOLI ORGANICS PRIVATE LTD (India), ERREGIERRE SPA (Italy), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), OLON SPA (Italy), SNJ LABS PVT LTD (India), PRANAMI DRUGS PRIVATE LTD (India) and BAYER HISPANIA, S.L. (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Clotrimazole Drug Master Files are active?

AMOLI ORGANICS PRIVATE LTD (DMF 26483), ERREGIERRE SPA (DMF 6324), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 7548), OLON SPA (DMF 9806), SNJ LABS PVT LTD (DMF 35902) and PRANAMI DRUGS PRIVATE LTD (DMF 44724). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Clotrimazole records mean?

6 organisations have only inactive Type II DMFs for Clotrimazole. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Clotrimazole have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Clotrimazole on the EDQM register, including AMOLI ORGANICS PRIVATE LIMITED Mumbai (IN), SNJ LABS PRIVATE LIMITED Rajkot (IN), BAYER HISPANIA, S.L. Langreo (ES), OLON S.P.A. Rodano (IT), F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore (IT) and ERREGIERRE S.P.A. San Paolo D'Argon (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Clotrimazole?

Yes. The latest patent listed for an approved US product containing Clotrimazole expires 26 May 2042, across 15 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Clotrimazole supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Clotrimazole?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.